MedTrace Logo

Haploidentical Donor vs mMUD in Hematological Malignancies

NCT03275636 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2024-08-07

No results posted yet for this study

Summary

The goal of this trial is to compare the outcome after partially matched (single mismatch) unrelated donor transplantation with haploidentical transplantation in a randomized controlled setting.

Conditions

Interventions

BIOLOGICAL

Peripheral blood stem cells

Hematopoietic stem cell transplantation with PBSC

Sponsors & Collaborators

  • DKMS gemeinnützige GmbH

    lead OTHER

Principal Investigators

  • Johannes Schetelig, Prof Dr med · Universtitätsklinikum Dresden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2024-04-13
Completion
2024-04-13

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03275636 on ClinicalTrials.gov